Roivant Sciences (ROIV) Share-based Compensation (2020 - 2026)

Roivant Sciences (ROIV) has 6 years of Share-based Compensation data on file, last reported at $269.0 million in Q4 2025.

• Quarterly Share-based Compensation rose 30.87% year-over-year to $269.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $627.5 million (up 34.07% YoY) and the FY2026 annual result came in at $346.2 million, up 19.77% from the prior year.
• Share-based Compensation improved to $269.0 million in Q4 2025, from $70.8 million in the prior quarter.
• In the past five years, Share-based Compensation ranged from a high of $487.8 million in Q4 2021 to a low of $44000.0 in Q1 2025.
• A 5-year average of $102.1 million and a median of $57.0 million in 2022 frame the typical range for Share-based Compensation.
• Annual changes were most pronounced in 2021 — Share-based Compensation soared 3371.89% — and 2025, when it plunged 96.62%.
• Tracing ROIV's Share-based Compensation over 5 years: stood at $487.8 million in 2021, then slumped by 60.54% to $192.5 million in 2022, then decreased by 20.57% to $152.9 million in 2023, then jumped by 34.43% to $205.5 million in 2024, then jumped by 30.87% to $269.0 million in 2025.
• The last three Share-based Compensation figures came in at $269.0 million (Q4 2025), $70.8 million (Q3 2025), and $82.2 million (Q2 2025), per Business Quant data.